Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Jun 2025 is 5.74% vs -2.25% in Mar 2025
Consolidate Net Profit
QoQ Growth in quarter ended Jun 2025 is 400.00% vs -80.80% in Mar 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Jun 2025 is 15.09% vs -16.63% in Mar 2025
Interest
QoQ Growth in quarter ended Jun 2025 is -1.44% vs -8.37% in Mar 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2025 has improved from Mar 2025
Compare Quarterly Results Of Collegium Pharmaceutical, Inc. With
Quarterly - Net Sales
QoQ Growth in quarter ended Jun 2025 is 5.74% vs -2.25% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 29.39% vs 7.23% in Jun 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Jun 2025 is 400.00% vs -80.80% in Mar 2025
YoY Growth in quarter ended Jun 2025 is -38.78% vs 50.77% in Jun 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Jun 2025 is 15.09% vs -16.63% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 11.34% vs 12.18% in Jun 2024
Quarterly - Interest
QoQ Growth in quarter ended Jun 2025 is -1.44% vs -8.37% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 31.41% vs -28.77% in Jun 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2025 has improved from Mar 2025
YoY Growth in quarter ended Jun 2025 has fallen from Jun 2024






